Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Our Products
MouseAtlas
iPSC Cell Lines
Knockout Cell Lines
Tumor Cell Lines
Adeno-associated Virus (AAV) Standard Capsid
Featured Catalog
Humanized Mouse Models
HUGO-Ab™
Target-Humanized Mouse Models (HUGO-GT™)
Target-Humanized Mouse Models (CDS)
Humanized Immune System Mouse Models
Tool Mice
Cre Mouse Lines
Disease Models
Autoimmune Disease Models
Ophthalmic Disease Models
Immunodeficient Mouse Models
Metabolic Disease Models
Neurological Disease Models
Oncology & Immuno-oncology Models
Custom Model Services
Model Generation Techniques
Turboknockoutᵀᴹ Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Genetically Engineered Animals
Knockin Mice
Knockin Rats
Knockout Mice
Knockout Rats
Transgenic Mice
Transgenic Rats
Transgenic Model Generation
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Adenovirus Packaging
Lentivirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Overexpression Cell Lines
Point Mutation Cell Lines
Breeding & Supporting Services
BAC Modification
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
Preclinical Solutions
Antibody Discovery Platform
HUGO-Mab™
HUGO-Light™
HUGO-Nano™
HUGO-Ab-eKO™
Therapeutic Area
Neurology
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Blood Brain Barrier (BBB)
Neuropathic Pain
Metabolic
Obesity
MASH & MASLD
Cardiovascular
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Retinal-related diseases
Oncology
PBMC Humanized Mouse Model
Human Immune System (HIS) Mouse Model
Immunology & Inflammation
Asthma
Systemic Lupus Erythematosus
Drug Classification
Therapeutic Antibody Drugs
Monoclonal Antibodies (mAb)
Bispecific Antibodies (BsAb)
ADC/AOC
AI-Powered AAV Discovery
Cell Immunotherapy
Gene Therapy
Oligonucleotide Therapy
Fully Human Antibody Library
Neurology Antibodies
Metabolic & Cardiovascular Antibodies
Ophthalmology Antibodies
Oncology Antibodies
Immunology & Inflammation Antibodies
Resources
News
Blogs & Insight
Promotion
Events & Webinars
Databases
AbSeek
Rare Disease Data Center
Cell iGeneEditor™ System
iCyagen
Citations
Resource Vault
OriCell
About Us
Animal Health & Welfare
Company Overview
Facility Overview
Our Team
Our Partners
Careers
Health Reports
Contact Us
Login
HomeMouseAtlas
huMPZL2-Q74* Mouse
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Catalog Type
Product Name
Main Area of Research
How did you hear about us?
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.

huMPZL2-Q74* Mouse

Product Name
huMPZL2-Q74* Mouse
Product ID
C002132
Strain Name
C57BL/6Cya-Mpzl2tm1(hMPZL2*Q74X)/Cya
Background
C57BL/6Cya
Status
Live Mouse
When using this mouse strain in a publication, please cite “huMPZL2-Q74* Mouse (Catalog C002132) were purchased from Cyagen.”
HUGO-GT Humanized Models
Gene Editing Therapy
CAR-T
Product Type
Age
Genotype
Sex
Quantity
The standard delivery applies for a guaranteed minimum of three heterozygous carriers. Breeding services for homozygous carriers and/or specified sex are available.
+
Standard products are sold as live mice derived from cryorecovery or expansion. Frozen materials are available upon request. Pricing and lead times depend on real-time inventory.
HUGO-GT Humanized Models
Gene Editing Therapy
CAR-T

Basic Information

Related Resource
Basic Information
Gene Name
MPZL2
Gene Alias
EVA, EVA1, DFNB111
NCBI ID
10205 (Human)
Chromosome
Chr 11 (Human)
MGI ID
MGI:1289160
Datasheet
Click here to download >>

Strain Description

Myelin protein zero-like 2 (MPZL2), also known as epithelial V-like antigen 1 (EVA1), is a single-pass type I transmembrane glycoprotein of the immunoglobulin superfamily that contains an Ig-like V-type domain in its extracellular region and mediates homophilic cell-cell adhesion [1]. MPZL2 is widely expressed; among fetal tissues the highest expression is found in the inner ear, whereas among adult tissues the highest levels are found in the thymus and lung [2]. Biallelic loss of MPZL2 function causes autosomal recessive non-syndromic deafness (DFNB111), in which patients present with early-onset, progressive sensorineural hearing loss without vestibular involvement [2-3]. Among DFNB111 patients of East Asian ancestry, most carry the c.220C>T (p.Q74*) variant, which is considered a founder mutation in East Asian populations [4-5]. MPZL2 has been regarded as a potential therapeutic target for DFNB111, and the relevant interventions remain at the preclinical stage, including adeno-associated virus (AAV)-mediated human MPZL2 gene supplementation and base editing to correct the c.220C>T mutation [5-6].
The huMPZL2-Q74* mouse is a humanized model in which the sequence from upstream of the mouse Mpzl2 start codon to downstream of the 3'UTR was replaced with the corresponding sequence of the human MPZL2 gene, and the p.Q74* (CAG to TAG) mutation was introduced into exon 2 of the human MPZL2 gene. This model can be used for studying the pathogenesis of DFNB111, as well as for screening, development, and preclinical in vivo evaluation of MPZL2-targeted therapies.
Reference
Güttinger M, Sutti F, Panigada M, et al. Epithelial V-like antigen (EVA), a novel member of the immunoglobulin superfamily, expressed in embryonic epithelia with a potential role as homotypic adhesion molecule in thymus histogenesis. J Cell Biol. 1998;141(4):1061-1071. doi:10.1083/jcb.141.4.1061
Wesdorp M, Murillo-Cuesta S, Peters T, et al. MPZL2, encoding the epithelial junctional protein myelin protein zero-like 2, is essential for hearing in man and mouse. Am J Hum Genet. 2018;103(1):74-88. doi:10.1016/j.ajhg.2018.05.011
Bademci G, Abad C, Incesulu A, et al. MPZL2 is a novel gene associated with autosomal recessive nonsyndromic moderate hearing loss. Hum Genet. 2018;137(6-7):479-486. doi:10.1007/s00439-018-1901-4
Li W, Guo L, Chen B, Shu Y, Li H. MPZL2 variant analysis with whole exome sequencing in a cohort of Chinese hearing loss patients. Int J Pediatr Otorhinolaryngol. 2023;171:111635. doi:10.1016/j.ijporl.2023.111635
Hu SW, Jeong S, Jiang L, et al. PAM-flexible adenine base editing rescues hearing loss in a humanized MPZL2 mouse model harboring an East Asian founder mutation. Nat Commun. 2025;16:7186. doi:10.1038/s41467-025-62562-8
Jang SH, Song HG, Joo SY, et al. Gene supplementation with precise transgene expression rescues hearing loss in a mouse model with an Mpzl2 East Asian founder variant. Mol Ther. 2026;34(1):216-231. doi:10.1016/j.ymthe.2025.10.005

Strain Strategy

The sequence from upstream of the mouse Mpzl2 start codon to downstream of the 3'UTR was replaced with the corresponding sequence of the human MPZL2 gene, and the p.Q74* (CAG to TAG) mutation was introduced into exon 2 of the human MPZL2 gene.
Figure 1. Gene editing strategy of huMPZL2-Q74* mice.
Figure 1. Gene editing strategy of huMPZL2-Q74* mice.

Application Area

Pathogenesis studies of DFNB111 and other hereditary hearing loss;
Research and development, screening, and preclinical in vivo evaluation of MPZL2-targeted therapies and gene therapy strategies.
Related Resource
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Inquiry Details
Main Area of Research
Service(s) of Interest
Gene of Interest
Project Details
How did you hear about us?
Contact Information
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our  Privacy Policy  for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Services
HUGO-GT™HUGO-Ab™iPSC Cell LinesAdeno-associated Virus (AAV) Standard Capsid
Drug R&D
NeurologyMetabolicOphthalmologyOncology
About Us
Animal Health & WelfareCompany OverviewOur TeamHealth Reports
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2026 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research